List of Auryxia drug patents

Auryxia is owned by Keryx Biopharms.

Auryxia contains Ferric Citrate.

Auryxia has a total of 15 drug patents out of which 1 drug patent has expired.

Expired drug patents of Auryxia are:

  • US5753706

Auryxia was authorised for market use on 05 September, 2014.

Auryxia is available in tablet;oral dosage forms.

Auryxia can be used as control of serum phosphorus levels, control of serum phosphorous levels.

The generics of Auryxia are possible to be released after 21 July, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9328133 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US9757416 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US8338642 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US7767851 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5753706 KERYX BIOPHARMS Methods for treating renal failure
Feb, 2022

(1 year, 4 days ago)

US8299298 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Feb, 2024

(1 year, 10 days from now)

US8754257 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US8609896 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US9050316 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US8846976 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US8901349 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US8754258 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(1 year, 10 days from now)

US8093423 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Apr, 2026

(3 years from now)

US10300039 KERYX BIOPHARMS Ferric citrate dosage forms
Jul, 2030

(7 years from now)

US9387191 KERYX BIOPHARMS Ferric citrate dosage forms
Jul, 2030

(7 years from now)

Drugs and Companies using FERRIC CITRATE ingredient

Market Authorisation Date: 05 September, 2014

Treatment: Control of serum phosphorous levels; Control of serum phosphorus levels

Dosage: TABLET;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic